{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T01:18:48Z","timestamp":1768267128054,"version":"3.49.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T00:00:00Z","timestamp":1516233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T00:00:00Z","timestamp":1516233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mucopolysaccharidosis (MPS) IIIB is an inherited lysosomal storage disease caused by the deficiency of the enzyme \u03b1-<jats:italic>N<\/jats:italic>-acetylglucosaminidase (NAGLU) required for heparan sulfate (HS) degradation. The defective lysosomal clearance of undigested HS results in dysfunction of multiple tissues and organs. We recently demonstrated that the murine model of MPS IIIB develops cardiac disease, valvular abnormalities, and ultimately heart failure. To address the molecular mechanisms governing cardiac dysfunctions in MPS IIIB, we generated a model of the disease by silencing NAGLU gene expression in H9C2 rat cardiomyoblasts. NAGLU-depleted H9C2 exhibited accumulation of abnormal lysosomes and a hypertrophic phenotype. Furthermore, we found the specific activation of the epidermal growth factor receptor (EGFR), and increased phosphorylation levels of extracellular signal-regulated kinases (ERKs) in NAGLU-depleted H9C2. The inhibition of either EGFR or ERKs, using the selective inhibitors AG1478 and PD98059, resulted in the reduction of both lysosomal aberration and hypertrophy in NAGLU-depleted H9C2. We also found increased phosphorylation of c-Src and a reduction of the hypertrophic response in NAGLU-depleted H9C2 transfected with a dominant-negative c-Src. However, c-Src phosphorylation remained unaffected by AG1478 treatment, posing c-Src upstream EGFR activation. Finally, heparin-binding EGF-like growth factor (HB-EGF) protein was found overexpressed in our MPS IIIB cellular model, and its silencing reduced the hypertrophic response. These results indicate that both c-Src and HB-EGF contribute to the hypertrophic phenotype of NAGLU-depleted cardiomyoblasts by synergistically activating EGFR and subsequent signaling, thus suggesting that EGFR pathway inhibition could represent an effective therapeutic approach for MPS IIIB cardiac disease.<\/jats:p>","DOI":"10.1038\/s41419-017-0187-0","type":"journal-article","created":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T16:43:38Z","timestamp":1516293818000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["EGFR activation triggers cellular hypertrophy and lysosomal disease in NAGLU-depleted cardiomyoblasts, mimicking the hallmarks of mucopolysaccharidosis IIIB"],"prefix":"10.1038","volume":"9","author":[{"given":"Valeria","family":"De Pasquale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Pezone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Sarogni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Tramontano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele Giacomo","family":"Schiattarella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittorio Enrico","family":"Avvedimento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Paladino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5145-7428","authenticated-orcid":false,"given":"Luigi Michele","family":"Pavone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,18]]},"reference":[{"key":"187_CR1","unstructured":"Neufeld, E. F. & Muenzer, J. in The Metabolic and Molecular Bases of Inherited Disease 8th edn (eds Scriver, C. R., Beaudet, A. L., Sly, W. S. & Valle, D) 3421\u20133452 (McGraw-Hill, New York, USA, 2001)."},{"key":"187_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.matbio.2015.02.003","volume":"42","author":"RV Iozzo","year":"2015","unstructured":"Iozzo, R. V. & Schaefer, L. Proteoglycan form and function: a comprehensive nomenclature of proteoglycans. Matrix Biol. 42, 11\u201355 (2015).","journal-title":"Matrix Biol."},{"key":"187_CR3","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s10545-011-9359-8","volume":"34","author":"EA Braunlin","year":"2011","unstructured":"Braunlin, E. A. et al. Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management. J. Inherit. Metab. Dis. 34, 1183\u20131197 (2011).","journal-title":"J. Inherit. Metab. Dis."},{"key":"187_CR4","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1017\/S104795110999062X","volume":"20","author":"GN Leal","year":"2010","unstructured":"Leal, G. N., de Paula, A. C., Leone, C. & Kim, C. A. Echocardiographic study of paediatric patients with mucopolysaccharidosis. Cardiol. Young 20, 254\u2013261 (2010).","journal-title":"Cardiol. Young"},{"key":"187_CR5","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s004310050872","volume":"157","author":"JH Dangel","year":"1998","unstructured":"Dangel, J. H. Cardiovascular changes in children with mucopolysaccharide storage diseases and related disorders\u2013clinical and echocardiographic findings in 64 patients. Eur. J. Pediatr. 157, 534\u2013538 (1998).","journal-title":"Eur. J. Pediatr."},{"key":"187_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000064674","volume":"98","author":"D Rigante","year":"2002","unstructured":"Rigante, D. & Segni, G. Cardiac structural involvement in mucopolysaccharidoses. Cardiology 98, 18\u201320 (2002).","journal-title":"Cardiology"},{"key":"187_CR7","doi-asserted-by":"publisher","first-page":"14505","DOI":"10.1073\/pnas.96.25.14505","volume":"96","author":"HH Li","year":"1999","unstructured":"Li, H. H. et al. Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase. Proc. Natl Acad. Sci. USA 96, 14505\u201314510 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"187_CR8","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1093\/hmg\/ddr584","volume":"21","author":"E Roy","year":"2012","unstructured":"Roy, E. et al. GM130 gain-of-function induces cell pathology in a model of lysosomal storage disease. Hum. Mol. Genet. 21, 1481\u20131495 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"187_CR9","doi-asserted-by":"publisher","first-page":"36194","DOI":"10.1074\/jbc.M114.599944","volume":"289","author":"HA Watson","year":"2014","unstructured":"Watson, H. A. et al. Heparan sulfate inhibits hematopoietic stem and progenitor cell migration and engraftment in mucopolysaccharidosis I. J. Biol. Chem. 289, 36194\u201336203 (2014).","journal-title":"J. Biol. Chem."},{"key":"187_CR10","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1182\/blood-2005-02-0657","volume":"106","author":"C Pan","year":"2005","unstructured":"Pan, C. et al. Functional abnormalities of heparan sulphate in mucopolysaccharidosis-I are associated with defective biologic activity of FGF-2 on human multipotent progenitor cells. Blood 106, 1956\u20131964 (2005).","journal-title":"Blood"},{"key":"187_CR11","doi-asserted-by":"publisher","first-page":"e27461","DOI":"10.1371\/journal.pone.0027461","volume":"6","author":"K Ohmi","year":"2011","unstructured":"Ohmi, K., Zhao, H. Z. & Neufeld, E. F. Defects in the medial entorhinal cortex and dentate gyrus in the mouse model of Sanfilippo syndrome type B. PLoS ONE 6, e27461 (2011).","journal-title":"PLoS ONE"},{"key":"187_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11011-010-9230-x","volume":"26","author":"DM McCarty","year":"2011","unstructured":"McCarty, D. M. et al. Differential distribution of heparan sulfate glycoforms and elevated expression of heparan sulfate biosynthetic enzyme genes in the brain of mucopolysaccharidosis IIIB mice. Metab. Brain Dis. 26, 9\u201319 (2011).","journal-title":"Metab. Brain Dis."},{"key":"187_CR13","doi-asserted-by":"publisher","first-page":"e35787","DOI":"10.1371\/journal.pone.0035787","volume":"7","author":"FL Wilkinson","year":"2012","unstructured":"Wilkinson, F. L. et al. Neuropathology in mouse models of mucopolysaccharidosis type I, IIIA and IIIB. PLoS ONE 7, e35787 (2012).","journal-title":"PLoS ONE"},{"key":"187_CR14","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.bbamcr.2008.12.001","volume":"1793","author":"A Ballabio","year":"2009","unstructured":"Ballabio, A. & Gieselmann, V. Lysosomal disorders: from storage to cellular cellular damage. Biochim. Biophys. Acta 1793, 684\u2013696 (2009).","journal-title":"Biochim. Biophys. Acta"},{"key":"187_CR15","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1146\/annurev.biochem.68.1.729","volume":"68","author":"M Bernfield","year":"1999","unstructured":"Bernfield, M. et al. Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68, 729\u2013777 (1999).","journal-title":"Annu. Rev. Biochem."},{"key":"187_CR16","doi-asserted-by":"publisher","first-page":"22029","DOI":"10.1074\/jbc.M109.002840","volume":"284","author":"C Faye","year":"2009","unstructured":"Faye, C. et al. Molecular interplay between endostatin, integrins, and heparan sulfate. J. Biol. Chem. 284, 22029\u201322040 (2009).","journal-title":"J. Biol. Chem."},{"key":"187_CR17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1530\/JOE-10-0377","volume":"209","author":"SH Kim","year":"2011","unstructured":"Kim, S. H., Turnbull, J. & Guimond, S. Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor. J. Endocrinol. 209, 139\u2013151 (2011).","journal-title":"J. Endocrinol."},{"key":"187_CR18","first-page":"739","volume":"26","author":"K Shimamura","year":"1976","unstructured":"Shimamura, K., Hakozaki, H. & Takahashi, K. et al. Sanfilippo B syndrome. A case report. Acta Pathol. Jpn. 26, 739\u2013764 (1976).","journal-title":"Acta Pathol. Jpn."},{"key":"187_CR19","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/0002-9149(88)91325-2","volume":"61","author":"DM Gross","year":"1988","unstructured":"Gross, D. M., Williams, J. C., Caprioli, C., Dominguez, B. & Howell, R. R. Echocardiographic abnormalities in the mucopolysaccharide storage diseases. Am. J. Cardiol. 61, 170\u2013176 (1988).","journal-title":"Am. J. Cardiol."},{"key":"187_CR20","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/BF00796996","volume":"14","author":"J Muenzer","year":"1993","unstructured":"Muenzer, J., Beekman, R. H., Profera, L. M. & Bove, E. L. Severe mitral insufficiency in mucopolysaccharidosis type III-B (Sanfilippo syndrome). Pediatr. Cardiol. 14, 130\u2013132 (1993).","journal-title":"Pediatr. Cardiol."},{"key":"187_CR21","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/BF01991908","volume":"154","author":"CF Wippermann","year":"1995","unstructured":"Wippermann, C. F. et al. Mitral and aortic regurgitation in 84 patients with mucopolysaccharidoses. Eur. J. Pediatr. 154, 98\u2013101 (1995).","journal-title":"Eur. J. Pediatr."},{"key":"187_CR22","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1016\/j.ijcard.2006.11.054","volume":"122","author":"S Kourouklis","year":"2007","unstructured":"Kourouklis, S. et al. Outlet type of interventricular septal defect in SanFilippo type-B syndrome. Int. J. Cardiol. 122, e4\u2013e5 (2007).","journal-title":"Int. J. Cardiol."},{"key":"187_CR23","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.ymgme.2014.02.009","volume":"111","author":"SM Lin","year":"2014","unstructured":"Lin, S. M., Lin, H. Y., Chuang, C. K., Lin, S. P. & Chen, M. R. Cardiovascular abnormalities in Taiwanese patients with mucopolysaccharidosis. Mol. Genet. Metab. 111, 493\u2013498 (2014).","journal-title":"Mol. Genet. Metab."},{"key":"187_CR24","doi-asserted-by":"publisher","first-page":"e0131662","DOI":"10.1371\/journal.pone.0131662","volume":"10","author":"GG Schiattarella","year":"2015","unstructured":"Schiattarella, G. G. et al. The murine model of mucopolysaccharidosis IIIB develops cardiopathies over time leading to heart failure. PLoS ONE 10, e0131662 (2015).","journal-title":"PLoS ONE"},{"key":"187_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11626-010-9368-1","volume":"47","author":"SJ Watkins","year":"2011","unstructured":"Watkins, S. J., Borthwick, G. M. & Arthur, H. M. The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro.  Vitr. Cell Dev. Biol. Anim. 47, 125\u2013131 (2011).","journal-title":"Vitr. Cell Dev. Biol. Anim."},{"key":"187_CR26","doi-asserted-by":"publisher","first-page":"29063","DOI":"10.1074\/jbc.274.41.29063","volume":"274","author":"C M\u00e9nard","year":"1999","unstructured":"M\u00e9nard, C. et al. Modulation of L-type calcium channel expression during retinoic acid-induced differentiation of H9C2 cardiac cells. J. Biol. Chem. 274, 29063\u201329070 (1999).","journal-title":"J. Biol. Chem."},{"key":"187_CR27","doi-asserted-by":"crossref","first-page":"20488","DOI":"10.1016\/S0021-9258(17)30530-6","volume":"265","author":"SR Carlsson","year":"1990","unstructured":"Carlsson, S. R. & Fukuda, M. The polylactosaminoglycans of human lysosomal membrane glycoproteins lamp-1 and lamp-2. Localization on the peptide backbones. J. Biol. Chem. 265, 20488\u201320495 (1990).","journal-title":"J. Biol. Chem."},{"key":"187_CR28","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1016\/j.bbadis.2013.07.003","volume":"1832","author":"IA Sergeeva","year":"2013","unstructured":"Sergeeva, I. A. & Christoffels, V. M. Regulation of expression of atrial and brain natriuretic peptide, biomarkers for heart development and disease. Biochim. Biophys. Acta 1832, 2403\u20132413 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"187_CR29","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1126\/science.7892601","volume":"267","author":"A Levitzki","year":"1995","unstructured":"Levitzki, A. & Gazit, A. Tyrosine kinase inhibition: an approach to drug development. Science 267, 1782\u20131788 (1995).","journal-title":"Science"},{"key":"187_CR30","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/sj.ejhg.5201623","volume":"14","author":"E Piotrowska","year":"2006","unstructured":"Piotrowska, E. et al. Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses. Eur. J. Hum. Genet. 14, 846\u2013852 (2006).","journal-title":"Eur. J. Hum. Genet."},{"key":"187_CR31","doi-asserted-by":"publisher","first-page":"17054","DOI":"10.1074\/jbc.M114.555300","volume":"289","author":"M Moskot","year":"2014","unstructured":"Moskot, M. et al. The phytoestrogen genistein modulates lysosomal metabolism and transcription factor EB (TFEB) activation. J. Biol. Chem. 289, 17054\u201317069 (2014).","journal-title":"J. Biol. Chem."},{"key":"187_CR32","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s10545-014-9703-x","volume":"37","author":"SD Kingma","year":"2014","unstructured":"Kingma, S. D., Wagemans, T., IJlst, L., Wijburg, F. A. & van Vlies, N. Genistein increases glycosaminoglycan levels in mucopolysaccharidosis type I cell models. J. Inherit. Metab. Dis. 37, 813\u2013821 (2014).","journal-title":"J. Inherit. Metab. Dis."},{"key":"187_CR33","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1161\/01.RES.0000038488.38975.1A","volume":"91","author":"OF Bueno","year":"2002","unstructured":"Bueno, O. F. & Molkentin, J. D. Involvement of extracellular signal-regulated kinases 1\/2 in cardiac hypertrophy and cell death. Circ. Res. 91, 776\u2013781 (2002).","journal-title":"Circ. Res."},{"key":"187_CR34","doi-asserted-by":"publisher","first-page":"29490","DOI":"10.1074\/jbc.M100699200","volume":"276","author":"DC Ng","year":"2001","unstructured":"Ng, D. C., Long, C. S. & Bogoyevitch, M. A. A role for the extracellular signal-regulated kinase and p38 mitogen-activated protein kinases in interleukin-1 beta-stimulated delayed signal tranducer and activator of transcription 3 activation, atrial natriuretic factor expression, and cardiac myocyte morphology. J. Biol. Chem. 276, 29490\u201329498 (2001).","journal-title":"J. Biol. Chem."},{"key":"187_CR35","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.cellsig.2011.07.005","volume":"23","author":"LM Pavone","year":"2011","unstructured":"Pavone, L. M. et al. Intracellular signaling cascades triggered by the NK1 fragment of hepatocyte growth factor in human prostate epithelial cell line PNT1A. Cell Signal. 23, 1961\u20131971 (2011).","journal-title":"Cell Signal."},{"key":"187_CR36","doi-asserted-by":"publisher","first-page":"8335","DOI":"10.1074\/jbc.274.12.8335","volume":"274","author":"JS Biscardi","year":"1999","unstructured":"Biscardi, J. S. et al. c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. J. Biol. Chem. 274, 8335\u20138343 (1999).","journal-title":"J. Biol. Chem."},{"key":"187_CR37","doi-asserted-by":"publisher","first-page":"49293","DOI":"10.1074\/jbc.M307021200","volume":"278","author":"WJ Wu","year":"2003","unstructured":"Wu, W. J., Wang, J. & Cerione, R. A. Epidermal growth factor-dependent regulation of Cdc42 is mediated by the Src tyrosine kinase. J. Biol. Chem. 278, 49293\u201349300 (2003).","journal-title":"J. Biol. Chem."},{"key":"187_CR38","volume":"9","author":"HL Hsieh","year":"2012","unstructured":"Hsieh, H. L., Lin, C. C., Chan, H. J., Yang, C. & Yang, C. M. c-Src-dependent EGF receptor transactivation contributes to ET-1-induced COX-2 expression in brain microvascular endothelial cells. J. Neuroinflamm. 9, 152 (2012).","journal-title":"J. Neuroinflamm."},{"key":"187_CR39","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1242\/jcs.058321","volume":"123","author":"RN Prince","year":"2010","unstructured":"Prince, R. N. et al. The heparin-binding domain of HB-EGF mediates localization to sites of cell-cell contact and prevents HB-EGF proteolytic release. J. Cell Sci. 123, 2308\u20132318 (2010).","journal-title":"J. Cell Sci."},{"key":"187_CR40","doi-asserted-by":"publisher","first-page":"10622","DOI":"10.1073\/pnas.0501198102","volume":"102","author":"J Yoshioka","year":"2005","unstructured":"Yoshioka, J. et al. Cardiomyocyte hypertrophy and degradation of connexin43 through spatially restricted autocrine\/paracrine heparin-binding EGF. Proc. Natl Acad. Sci. USA 102, 10622\u201310627 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"187_CR41","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","volume":"65","author":"N Frey","year":"2003","unstructured":"Frey, N. & Olson, E. N. Cardiac hypertrophy: the good, the bad, and the ugly. Annu. Rev. Physiol. 65, 45\u201379 (2003).","journal-title":"Annu. Rev. Physiol."},{"key":"187_CR42","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.115.013894","volume":"131","author":"GG Schiattarella","year":"2015","unstructured":"Schiattarella, G. G. & Hill, J. A. Inhibition of hypertrophy is a good therapeutic strategy in ventricular pressure overload. Circulation 131, 1435\u20131447 (2015).","journal-title":"Circulation"},{"key":"187_CR43","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00395-011-0163-2","volume":"106","author":"G Esposito","year":"2011","unstructured":"Esposito, G. et al. EGFR trans-activation by urotensin II receptor is mediated by \u03b2-arrestin recruitment and confers cardioprotection in pressure overload-induced cardiac hypertrophy. Basic Res. Cardiol. 106, 577\u2013589 (2011).","journal-title":"Basic Res. Cardiol."},{"key":"187_CR44","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/jcmm.12763","volume":"20","author":"K Peng","year":"2016","unstructured":"Peng, K. et al. Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II. J. Cell Mol. Med. 20, 482\u2013494 (2016).","journal-title":"J. Cell Mol. Med."},{"key":"187_CR45","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ana.22643","volume":"71","author":"J de Ruijter","year":"2012","unstructured":"de Ruijter, J. et al. Genistein in Sanfilippo disease: a randomized controlled crossover trial. Ann. Neurol. 71, 110\u2013120 (2012).","journal-title":"Ann. Neurol."},{"key":"187_CR46","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nrm1983","volume":"7","author":"J Heineke","year":"2006","unstructured":"Heineke, J. & Molkentin, J. D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat. Rev. Mol. Cell Biol. 7, 589\u2013600 (2006).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"187_CR47","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.biocel.2008.09.032","volume":"41","author":"N Duquesnes","year":"2009","unstructured":"Duquesnes, N., Vincent, F., Morel, E., Lezoualc\u2019h, F. & Crozatier, B. The EGF receptor activates ERK but not JNK Ras-dependently in basal conditions but ERK and JNK activation pathways are predominantly Ras-independent during cardiomyocyte stretch. Int. J. Biochem. Cell Biol. 41, 1173\u20131181 (2009).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"187_CR48","doi-asserted-by":"publisher","first-page":"4637","DOI":"10.1074\/jbc.272.7.4637","volume":"272","author":"LM Luttrell","year":"1997","unstructured":"Luttrell, L. M., Della Rocca, G. J., van Biesen, T., Luttrell, D. K. & Lefkowitz, R. J. Gbetagamma subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation. J. Biol. Chem. 272, 4637\u20134644 (1997).","journal-title":"J. Biol. Chem."},{"key":"187_CR49","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1515\/bmc-2014-0003","volume":"5","author":"J Reinecke","year":"2014","unstructured":"Reinecke, J. & Caplan, S. Endocytosis and the Src family of non-receptor tyrosine kinases. Biomol. Concepts 5, 143\u2013155 (2014).","journal-title":"Biomol. Concepts"},{"key":"187_CR50","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.lfs.2013.03.017","volume":"92","author":"PJ Little","year":"2013","unstructured":"Little, P. J. GPCR responses in vascular smooth muscle can occur predominantly through dual transactivation of kinase receptors and not classical G\u03b1q protein signalling pathways. Life Sci. 92, 951\u2013956 (2013).","journal-title":"Life Sci."},{"key":"187_CR51","doi-asserted-by":"publisher","first-page":"19700","DOI":"10.3390\/ijms151119700","volume":"15","author":"F Cattaneo","year":"2014","unstructured":"Cattaneo, F. et al. Cell-surface receptors transactivation mediated by g protein-coupled receptors. Int. J. Mol. Sci. 15, 19700\u201319728 (2014).","journal-title":"Int. J. Mol. Sci."},{"key":"187_CR52","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1242\/dev.048926","volume":"137","author":"R Iwamoto","year":"2010","unstructured":"Iwamoto, R. et al. HB-EGF function in cardiac valve development requires interaction with heparan sulfate proteoglycans. Development 137, 2205\u20132214 (2010).","journal-title":"Development"},{"key":"187_CR53","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.cellsig.2011.01.006","volume":"23","author":"KS Lee","year":"2011","unstructured":"Lee, K. S., Park, J. H., Lim, H. J. & Park, H. Y. HB-EGF induces cardiomyocyte hypertrophy via an ERK5-MEF2A-COX2 signaling pathway. Cell Signal. 23, 1100\u20131109 (2011).","journal-title":"Cell Signal."},{"key":"187_CR54","doi-asserted-by":"publisher","first-page":"7957","DOI":"10.1074\/jbc.M008570200","volume":"276","author":"S Eguchi","year":"2001","unstructured":"Eguchi, S., Dempsey, P. J., Frank, G. D., Motley, E. D. & Inagami, T. Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK. J. Biol. Chem. 276, 7957\u20137962 (2001).","journal-title":"J. Biol. Chem."},{"key":"187_CR55","doi-asserted-by":"publisher","first-page":"4613","DOI":"10.1128\/MCB.24.11.4613-4626.2004","volume":"24","author":"L Cardone","year":"2004","unstructured":"Cardone, L. et al. Mitochondrial AKAP121 binds and targets protein tyrosine phosphatase D1, a novel positive regulator of src signaling. Mol. Cell Biol. 24, 4613\u20134626 (2004).","journal-title":"Mol. Cell Biol."},{"key":"187_CR56","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1399-0004.1985.tb00217.x","volume":"27","author":"J Marsh","year":"1985","unstructured":"Marsh, J. & Fensom, A. H. 4-Methylumbelliferyl alpha-N-acetylglucosaminidase activity for diagnosis of Sanfilippo B disease. Clin. Genet. 27, 258\u2013262 (1985).","journal-title":"Clin. Genet."},{"key":"187_CR57","doi-asserted-by":"crossref","first-page":"prot5621","DOI":"10.1101\/pdb.prot5621","volume":"2011","author":"B Chazotte","year":"2011","unstructured":"Chazotte, B. Labeling membranes with fluorescent phosphatidylethanolamine. Cold Spring Harb. Protoc. 2011, prot5621 (2011). pdb.","journal-title":"Cold Spring Harb. Protoc."},{"key":"187_CR58","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1242\/jcs.036038","volume":"121","author":"S Paladino","year":"2008","unstructured":"Paladino, S. et al. Different GPI-attachment signals affect the oligomerisation of GPI-anchored proteins and their apical sorting. J. Cell Sci. 121, 4001\u20134007 (2008).","journal-title":"J. Cell Sci."},{"key":"187_CR59","doi-asserted-by":"publisher","first-page":"ra84","DOI":"10.1126\/scisignal.2004592","volume":"7","author":"S Svegliati","year":"2014","unstructured":"Svegliati, S. et al. Oxidative DNA damage induces the ATM-mediated transcriptional suppression of the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis. Sci. Signal. 7, ra84 (2014).","journal-title":"Sci. Signal."},{"key":"187_CR60","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"187_CR61","doi-asserted-by":"publisher","first-page":"496","DOI":"10.2478\/s11658-010-0019-z","volume":"15","author":"C Auriemma","year":"2010","unstructured":"Auriemma, C. et al. Integrin receptors play a role in the internalin B-dependent entry of Listeria monocytogenes into host cells. Cell Mol. Biol. Lett. 15, 496\u2013506 (2010).","journal-title":"Cell Mol. Biol. Lett."},{"key":"187_CR62","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.nmd.2012.01.009","volume":"22","author":"LM Pavone","year":"2012","unstructured":"Pavone, L. M. et al. Role of serotonergic system in the pathogenesis of fibrosis in canine idiopathic inflammatory myopathies. Neuromuscul. Disord. 22, 549\u2013557 (2012).","journal-title":"Neuromuscul. Disord."},{"key":"187_CR63","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/ar.21353","volume":"294","author":"A Spina","year":"2011","unstructured":"Spina, A. et al. Fate map of serotonin transporter-expressing cells in developing mouse thyroid. Anat. Rec. 294, 384\u2013390 (2011).","journal-title":"Anat. Rec."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-017-0187-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-017-0187-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-017-0187-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T11:49:21Z","timestamp":1671536961000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-017-0187-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,18]]},"references-count":63,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2]]}},"alternative-id":["187"],"URL":"https:\/\/doi.org\/10.1038\/s41419-017-0187-0","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,18]]},"assertion":[{"value":"26 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"40"}}